US Stock MarketDetailed Quotes

InflaRx (IFRX)

Watchlist
  • 0.9755
  • +0.0055+0.57%
Trading Mar 9 11:45 ET
66.09MMarket Cap-1.38P/E (TTM)

InflaRx (IFRX) Revenue Breakdown Overview

By Business/Source

Currency:EUR
2025/Q3
Stock NameRevenueRatio
Product sales of GOHIBIC (vilobelimab)24K100.00%

By Country/Region

Currency:EUR
2024/FY
Stock NameRevenueRatio
United States165.79K100.00%
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the conflict between the US and Iran has continued, with the Strait of Hormuz at a standstill. A surge in oil prices, compounded b Show More